Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 467 results for "dr reddy"

Indian ADRs: Dr Reddy#39;s Lab slips 4%; Tata Motors, Infosys up
Money Control

Indian ADRs: ICICI Bank, Dr Reddy#39;s Labs gain; Infosys, HDF...

In the banking space, ICICI Bank rose 1.08 percent at USD 8.40 and HDFC Bank shed 0.21 percent at USD 72.85 while in the IT space Infosys was down 0.25 percent at USD 15.67 and Wipro slipped 0.04 percent at USD 10.16. Money Control, 1 day ago

449 images for dr reddy

Money Control, 2 days ago
Money Control, 3 days ago
Money Control, 5 days ago
Money Today, 5 days ago
Money Control, 5 days ago
Money Control, 5 days ago
Money Today, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Today, 1 month ago

Today's Picks: 22 March, 2017

Nifty, Bank Nifty, ITC, Aurobindo Pharma, Dr Reddy
 Business Standard4 days ago Today's picks: 21, March 2017  Business Standard5 days ago Today's Picks: January 10, 2017  Business Standard2 months ago Support for Nifty at 7950; Dr Reddy's Labs indicator buy: Gaba  Money Control2 months ago

Here’s what analysts feel about Dr Reddy’s Labs post US FDA observations

Typically, the US drug regulator conveys its concerns on manufacturing practices through Form 483. Companies that receive its observations must respond in writing with a corrective action plan and implement it quickly
 Money Control4 days ago Dr Reddy's Miryalaguda plant observations minor: Edelweiss  Money Control2 weeks ago Dr Reddy's gets 13 USFDA observations for Duvvada plant  Money Control2 weeks ago Can sort out USFDA concerns on Telangana plant: Dr Reddy's  Money Control3 weeks ago

Sell Dr Reddy’s Laboratories, Axis Bank, Bharat Forge, TVS Motor; buy ICICI Bank: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends selling Dr Reddy’s Laboratories, Axis Bank, Bharat Forge and TVS Motor and advises buying ICICI Bank.
 Money Control3 days ago Buy YES Bank, Dr Reddy's Labs may head lower: Sudarshan Sukhani  Money Control2 weeks ago Sell Dr. Reddy's Laboratories; target of Rs 2600: Axis Direct  Money Control3 weeks ago Accumulate Dr. Reddy’s Lab; target of Rs 3523: KR Choksey  Money Control1 month ago
Money Control

Stocks in news: Dr Reddy's, IDBI, Dish TV, Welspun Ent, Natco

Dr Reddy's Labs | IDBI Bank | Tata Steel | Cairn India | Maruti Suzuki | MRPL | Dish TV | Videocon | Welspun Enterprises | Natco Pharma | Alembic Pharma and Eros International are stocks, which are in the news today.
 Money Control3 days ago Sensex closes up 241 pts on HDFC ITC support; metals shine  Money Control3 weeks ago Stocks in news: Dr Reddy's, ITC, TCS, BEL, Axis, BPCL, Disa, ITD  Money Control1 month ago Nifty ends at 8734, Sensex up 85 pts amid consolidation; ITC up  Money Control1 month ago
Money Control

Sell Dr Reddy#39;s Laboratories on bounce: Sandeep Wagle

According to Sandeep Wagle of powermywealth.com, one may sell Dr Reddy#39;s Laboratories on bounce back towards Rs 2,700-2,750.
 Money Control4 days ago Exit Dr Reddy#39;s Laboratories: Shahina Mukadam  Money Control4 days ago Buy Tata Elxsi, Vedanta; sell Dr Reddy's Labs: Sandeep Wagle  Money Control2 months ago
Rediff.com

Dr Y V Reddy, Former Governor, RBI delivers 17th CVC lecture on “State and Market in India”

Dr Y V Reddy, Former Governor, Reserve Bank of India (RBI) delivered CVC lecture on “State and Market in India” here today. This was the 17th lecture of the “Lecture Series” organised by the Commission. Speaking on the occasion, Dr Y V Reddy said that ...
 PIB4 days ago RBI's autonomy and image 'dented beyond repair'  Rediff.com2 months ago RBI's identity has been damaged: Former gov  Rediff.com2 months ago
Rediff.com

How Dr Reddy's plans to win the US market

The company has launched only 3 new products during 2015 when compared to 14 launches in 2014 Dr Reddy’s Laboratories (DRL) is likely to leverage its relationship with existing and new partners to continue the momentum of product launches in the regulated markets. The company has launched only three new products during 2015 when compared to 14 launches in 2014. This sharp decline is due to a series of inspections and warning letters from the US Food and Drug Administration (FDA).
 Rediff.com1 week ago Dr Reddy's may leverage relationship with partners for new US launches  Business Standard1 week ago
Money Control

Market Live: Sensex, Nifty rebound; Idea Dr Reddys Labs down, Divis Labs tanks 17%

Divi#39;s Labs shares tanked 17 percent after the US Food and Drug Administration has issued an import alert for its Visakhapatnam unit-II.
 Money Control5 days ago Sensex, Nifty close flat ahead of exit polls; SBI, Maruti gain  Money Control2 weeks ago Live Market Updates: Sensex, Nifty sluggish ahead of exit polls; Dr Reddy’s down 4%  Money Control2 weeks ago Market extends budget day rally; Dr. Reddy's, Sunpharma top Sensex gainers  India Infoline1 month ago
[x]  
Money Today

Dr Reddy's Lab down 5% to hit 52-week low, top Sensex loser

The stock slipped 5% to Rs 2,602 on BSE in intra-day trade on back of heavy volumes.
 Business Standard5 days ago Dr Reddy's gets 13 observations from USFDA for Duwada facility  DNA2 weeks ago Dr Reddy's hits 52-week low on USFDA observations at Duvvada unit  Business Standard2 weeks ago Dr Reddy's gets 13 observations after USFDA inspection of its oncology formulation plant  Money Today2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less